% alzhub.org library filter
% Source: https://alzhub.org/research?category=drug_development&author=Balazs+Toth
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{abdelhaleem2026-40435316,
  author  = {Abdel-Haleem, Alyaa M and Casavant, Ellen and Toth, Balazs and Teng, Edmond and Monteiro, Cecilia and Pandya, Nikhil J and Glock, Caspar and Hoogenraad, Casper C and others},
  title   = {{CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures}},
  journal = {Brain : a journal of neurology},
  year    = {2026},
  doi     = {10.1093/brain/awaf200},
  pmid    = {40435316},
  url     = {https://doi.org/10.1093/brain/awaf200}
}

@article{schauer2024-39513754,
  author  = {Schauer, Stephen P and Toth, Balazs and Lee, Julie and Honigberg, Lee A and Ramakrishnan, Vidya and Jiang, Jenny and Kollmorgen, Gwendlyn and Bayfield, Anna and others},
  title   = {{Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.14346},
  pmid    = {39513754},
  url     = {https://doi.org/10.1002/alz.14346}
}

@article{sandoval2024-39369294,
  author  = {Sandoval, Cosme and Lee, Julie and Toth, Balazs and Nagaraj, Rajini and Schauer, Stephen P and Hoffman, Jennifer and Calderon, Emilia and Kollmorgen, Gwendlyn and others},
  title   = {{CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.14271},
  pmid    = {39369294},
  url     = {https://doi.org/10.1002/alz.14271}
}